消息

The Rio Tinto partnership has added considerable value through the major's thorough approach to project evaluation. Beyond Whistlejacket, BHL's Basin clay project already hosts a compliant resource, reinforcing the company's strategic value. Near‑term milestones for the Whistlejacket project include drilling expected before the end of July and a ma...

全文

Bradda Head Lithium Ltd's (BHL) executive chairman, Ian Stalker, recently discussed the company's Whistlejacket lithium project in Arizona with Proactive. Independent research from Greenwood Capital and Shard Capital has concluded that BHL could be worth significantly more than its current market valuation due to the company's diversified US portfo...

全文

The global pancreatic cancer market is expected to grow significantly, valued at $5.84 billion by 20230, with a CAGR of 12.3%, according to Grand View Research. This growth expectation looks promising for NVCR's Option Pax as a non‑invasive treatment option.

全文

The CE‑mark and FDA approval were supported by data from the phase III PANOVA‑3 study, which demonstrated a statistically significant improvement in median overall survival (mOS) and significantly extended time to pain progression. The study's results are promising for advanced‑stage pancreatic cancer patients, potentially driving strong adoption a...

全文

NovoCure Limited's NVCR portable medical device, Option Pax, has received the CE mark for treating adult patients with locally advanced pancreatic cancer of exocrine origin. This approval in Europe is concomitant with gemcitabine and nab‑paclitaxel (gem/nab‑pac) and aligns with guideline recommendations. The company plans to initiate the launch of...

全文

Industrial and logistics property group CTP has established an 11,500‑sqm distribution hub in CTPark Česká Lípa for Saint‑Gobain’s Sekurit Service. The facility will serve as a packaging centre for finished replacement glass products, supporting dispatch to warehouses across Europe and cutting supply times. The hub’s strategic location between Germ...

全文

Oppenheimer, in a note accompanying the earnings release, described the results as “solid,” noting top‑line strength and disciplined expense management. The firm highlighted a tick‑up in net retention and a growing list of AI‑enable products with strong customer traction. Oppenheimer emphasized continued debt paydown, a shift toward buybacks, and a...

全文

Management raised full‑year guidance. PRGS now expects fiscal‑year revenue between $990 million and just over $1 billion, with adjusted EPS ranging from $6.09 to $6.21. The outlook also includes adjusted free cash flow of $271 million to $283 million and unlevered free cash flow of $323 million to $334 million. CFO Folger projected Q3 revenue betwe...

全文

Following the release, PRGS shares surged 17.9 % in Wednesday’s trading, outperforming the S&P 500 and Nasdaq Composite. Despite the robust earnings beat, the stock has declined 21.2 % year‑to‑date, lagging the S&P 500’s 8.7 % gain. The company’s current Zacks Rank is #3 (Hold), suggesting near‑term market‑aligned performance.

全文

Financially, Impinj’s performance has been under pressure. Revenues fell in both the first quarter of 2026 and 2025, and the company continues to report net losses. The stock’s price‑to‑sales ratio sits above 11, well above the S&P 500 average, and its forward price‑to‑earnings ratio is in the mid‑60s (62.5x–63.4x). Despite generating a trailing 12...

全文